Gene · 1612
Papers4,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses. | Front Immunol | 2023 | 38143770 | PubTator, text mining | PubMed |
| Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. | Pharmaceutics | 2023 | 38140059 | PubTator, text mining | PubMed |
| Ca2+ Signaling and Src Functions in Tumor Cells. | Biomolecules | 2023 | 38136610 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns. | Cancer Cell Int | 2023 | 38129839 | PubTator, text mining | PubMed |
| Plasma Levels of mir-34a-5p Correlate with Systemic Inflammation and Low Naïve CD4 T Cells in Common Variable Immunodeficiency. | J Clin Immunol | 2023 | 38129593 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| miRGediNET: A comprehensive examination of common genes in miRNA-Target interactions and disease associations: Insights from a grouping-scoring-modeling approach. | Heliyon | 2023 | 38090011 | PubTator, text mining | PubMed |
| Research progress on the immune microenvironment and immunotherapy in gastric cancer. | Front Immunol | 2023 | 38077373 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | 38067304 | PubTator, text mining | PubMed |
| Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. | Acta Pharm Sin B | 2023 | 38045051 | PubTator, text mining | PubMed |
| Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders. | Haematologica | 2023 | 38037802 | PubTator, text mining | PubMed |
| Roles of microRNA-124 in traumatic brain injury: a comprehensive review. | Front Cell Neurosci | 2023 | 38034588 | PubTator, text mining | PubMed |
| Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma. | Infect Agent Cancer | 2023 | 38017473 | PubTator, text mining | PubMed |
| Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease. | Int J Mol Sci | 2023 | 38003448 | PubTator, text mining | PubMed |
| Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease. | Biomolecules | 2023 | 38002302 | PubTator, text mining | PubMed |
| Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. | Cancers (Basel) | 2023 | 38001653 | PubTator, text mining | PubMed |
| New insights into the genetic predisposition of brucellosis and its effect on the gut and vaginal microbiota in goats. | Sci Rep | 2023 | 37973848 | PubTator, text mining | PubMed |
| Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa. | ACS Omega | 2023 | 37970041 | PubTator, text mining | PubMed |
| Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). | Front Endocrinol (Lausanne) | 2023 | 37964963 | PubTator, text mining | PubMed |
| Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways. | Int J Mol Sci | 2023 | 37958702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1612/papers?page=11